Previous 10 | Next 10 |
2024-01-10 12:23:55 ET DENVER, Colo., Jan. 10, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Nauticus Robotics (NASDAQ: KITT), Clearmind Medicine Inc (NASDAQ: CMND), SEALSQ Corp (NASDAQ...
2024-01-10 10:13:12 ET DENVER, Colo., Jan. 10, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Clearmind Medicine Inc (NASDAQ: CMND), SEALSQ Corp (NASDAQ: LAES), iCoreConnect Inc (NASDAQ: ICCT), Nvni Grou...
2024-01-10 10:00:10 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and utilities could perform better in 2024 - analyst For further details see: See...
2024-01-10 09:28:25 ET More on Clearmind Medicine Inc. Clearmind climbs as psychedelic therapy offers hope in addiction Clearmind, SciSparc slide amid weight-loss study results Financial information for Clearmind Medicine Inc. For further details see: Cle...
2024-01-10 07:48:57 ET DENVER, Colo., Jan. 10, 2023 ( www.247marketnews.com )- Clearmind Medicine Inc. (NASDAQ: CMND) stated, this morning, that the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss its clinical trial of its proprietary...
Tel Aviv, Israel / Vancouver, Canada, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treat...
The collaboration included six different provisional patent applications filed by Clearmind with the United States Patent and Trademark Office in February 2023 to protect the novel combinations of psychedelics with SciSparc's PEA TEL AVIV, Israel, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Sci...
The collaboration included filing six different US patent applications with the United States Patent and Trademark Office to protect novel combinations of psychedelics with SciSparc's PEA Tel Aviv, Israel / Vancouver, Canada, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (N...
2023-12-14 11:51:48 ET More on Clearmind Medicine Inc. Clearmind climbs as psychedelic therapy offers hope in addiction Clearmind, SciSparc slide amid weight-loss study results Financial information for Clearmind Medicine Inc. For further details see: Cle...
Nasdaq Has Informed the Company That a Bid Price Deficiency of its Common Shares Has Been Cured Tel Aviv, Israel / Vancouver, Canada, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the "company"), a biotech company foc...
News, Short Squeeze, Breakout and More Instantly...
Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
Vancouver, Canada, July 16, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...